OneRobotics (Shenzhen) Co Ltd 06600.HKの前四半期の収益はどうでしたか?
OneRobotics (Shenzhen) Co Ltdの収益見積もりはいくらですか?
OneRobotics (Shenzhen) Co Ltdの収益品質スコアはどれくらいですか?
OneRobotics (Shenzhen) Co Ltdはいつ収益を報告しますか?
OneRobotics (Shenzhen) Co Ltdの予想収益はいくらですか?
OneRobotics (Shenzhen) Co Ltdは収益予想を上回りましたか?
主要データ
前終値
--
始値
--
当日レンジ
-
52週レンジ
-
取引高
--
平均取引高
--
1株当たり利益(TTM)
--
配当利回り
--
時価総額
--
OneRobotics (Shenzhen) Co Ltdとは何ですか?
SciClone Pharmaceuticals (Holdings) Ltd. is an investment holding company which manufactures and markets immune and oncology pharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 1,050 full-time employees. The firm and its subsidiaries are principally engaged in developing and commercializing a portfolio of marketed products as well as pipelines with potential in their focused therapeutic areas including oncology and severe infection. The Company’s main products comprise Zadaxin, Zometa, Oravig, Angiomax, Endoxan, Holoxan, Cytosafe, Farlutal, Campto and Vizimpro. The Company’s pipeline products include ORSERDU, Vaborem, Vibativ, RRx-001 and Omburtamab. The Company’s products are mainly used in fields such as tumors, urinary tract infections, and skin and soft tissue infections. The firm mainly conducts its businesses in the domestic market.